MELUZIO MICHAEL VINCENT (VP, Prin. Accounting Officer) sold 10.3% of their position (5.63K shares) of CUE BIOPHARMA, INC. on the open market
Open‑market sale worth $169.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/17/2026ACC: 0002138368-26-000007
Officer· VP, Prin. Accounting Officer
Since Jun 2026
-5.63K
Net shares
Net seller
$169.3K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
13.65K acquired · 19.27K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+13.65K
Price / share
—
Trade value
—
% of position
33.3%
8/13/2026
40.94K→54.59K
Common Stock
Direct
Shares
−1.52K
Price / share
$29.37
Trade value
$44.61K
% of position
2.8%
8/13/2026
54.59K→53.07K
Common Stock
Direct
Shares
−4.11K
Price / share
$30.35
Trade value
$124.62K
% of position
7.7%
8/13/2026
53.07K→48.96K
Common Stock
Direct
Shares
−3.00
Price / share
$31.13
Trade value
$93.39
% of position
0.0%
8/13/2026
48.96K→48.96K
Total
Net shares
+8.02K
Net value
-$169.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/13/2026 | M · Option Exercise | +13.65K | — | — | 33.3% | 40.94K | 54.59K |
| Common Stock Direct | 8/13/2026 | S · Sale | −1.52K | $29.37 | $44.61K | 2.8% | 54.59K | 53.07K |
| Common Stock Direct | 8/13/2026 | S · Sale | −4.11K | $30.35 | $124.62K | 7.7% | 53.07K | 48.96K |
| Common Stock Direct | 8/13/2026 | S · Sale | −3.00 | $31.13 | $93.39 | 0.0% | 48.96K | 48.96K |
| Total | +8.02K | -$169.32K | ||||||
Derivative Transactions1
Common Stock
Direct
Converts to
Common Stock
13.65K shares
Shares
−13.65K
Strike price
Held after
27.30K
Exercisable
—
8/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Direct | Common Stock13.65K shares | 8/13/2026 | M · Option Exercise | −13.65K | — | 27.30K |